Gastric cancer stem cells: A novel therapeutic target

Cancer Letters

Volumn 338, Issue 1, 2013, Pages 110-119

  Singh, Shree Ram ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; Gastric cancer; Gastric epithelial cells; Stem cells; Stomach

Indexed keywords

ABC TRANSPORTER G1; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BMI1 PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CD71 ANTIGEN; CELL MARKER; CISPLATIN; EPITHELIAL CELL ADHESION MOLECULE; FLUOROURACIL; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MULTIDRUG RESISTANCE PROTEIN 1; MUSASHI 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN ANTERIOR GRADIENT 2; PROTEIN DCAMKL1; PROTEIN DCKL1; PROTEIN LGR5; PROTEIN MIST1; PROTEIN TFF2; SMAD2 PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9; TRASTUZUMAB; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VILLIN;

APOPTOSIS; BONE MARROW CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL ASSAY; CELL LINEAGE; CELL RENEWAL; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HELICOBACTER INFECTION; HUMAN; MESENCHYME CELL; METASTASIS; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SHORT SURVEY; SIDE POPULATION CELL; STEM CELL NICHE; STEM CELL RESEARCH; STOMACH CANCER; STOMACH EPITHELIUM; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR MICROENVIRONMENT;

EID: 84882847908     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.03.035     Document Type: Review

References (160)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics,2002. CA Cancer J. Clin. 2005, 55:74-108.
2. Jemal A., Bray F., Center M.M., Ferlay J., et al. Global caner statistics. CA Cancer J. Clin. 2011, 61:69-90.
3. American Cancer Society Cancer Facts and Figures 2012 2012, American Cancer Society, Atlanta, GA.
4. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev.Cancer 2002, 2:28-37.
5. Suzuki H., Iwasaki E., Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer 2009, 12:79-87.
6. Milne A.N., Carneiro F., O'Morain C., Offerhaus G.J. Nature meets nurture: molecular genetics of gastric cancer. Hum. Genet. 2009, 126:615-628.
7. Tsugawa H., Suzuki H., Saya H., Hatakeyama M., et al. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed incancerstem-like cells. Cell Host Microbe. 2012, 12:764-777.
8. Wroblewski L.E., Peek R.M., Wilson K.T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 2010, 23:713-739.
9. Gomceli I., Demiriz B., Tez M. Gastriccarcinogenesis. World J. Gastroenterol. 2012, 18:5164-5170.
10. Ooi C.H., Ivanova T., Wu J., Lee M., Tan I.B., et al. Oncogenic pathway combinations predict clinical prognosis ingastriccancer. PLoS Genet. 2009, 5:e1000676.
11. Resende C., Thiel A., Machado J.C., Ristimäki A. Gastriccancer: basic aspects. Helicobacter 2011, 16:38-44.
12. Marshall B.J., Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1:1311-1315.
13. Tomita H., Yamada Y., Oyama T., Hata K., Hirose Y., et al. Development ofgastrictumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway. Cancer Res 2007, 67:4079-4087.
14. Ohnishi N., Yuasa H., Tanaka S., Sawa H., et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoieticneoplasmsin mouse. Proc. Natl. Acad. Sci. USA 2008, 105:1003-1008.
15. Kushima R., Vieth M., Borchard F., Stolte M., Mukaisho K., Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of thestomach. Gastric Cancer 2006, 9:177-184.
16. Yasui W., Sentani K., Sakamoto N., Anami K., Naito Y., Oue N. Molecular pathology ofgastric cancer: research and practice. Pathol. Res. Pract. 2011, 207:608-612.
17. Zouridis H., Deng N., Ivanova T., Zhu Y., Wong B., et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med. 2012, 4. 156ra140.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histopclinical classification. Acta Pathol. Microbiol. Scand. 1965, 64:31-49.
19. Nakamura K., Sugano H., Takagi K. Carcinoma of thestomachin incipient phase: its histogenesis and histological appearances. Gann. 1968, 59:251-258.
20. Mariotto A.B., Yabroff K.R., Shao Y., Feuer E.J., Brown M.L. Projections of the cost of cancer care in the United States: 2010-2020. J. Natl. Cancer Inst. 2011, 103:117-128.
21. Hartgrink H.H., Jansen E.P., van Grieken N.C., van de Velde C.J. Gastric cancer. Lancet 2009, 374:477-490.
22. Rocco A., Compare D., Nardone G. Cancerstem cell hypothesis andgastriccarcinogenesis: experimental evidence and unsolved questions. World J. Gastrointest. Oncol. 2012, 4:54-59.
23. Visvader J.E., Lindeman G.J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012, 10:717-728.
24. Hoffmann W. Regeneration of the gastric mucosa and its glands from stem cells. Curr. Med. Chem. 2008, 15:3133-3144.
25. Hoffmann W. Stem cells, self-renewal and cancer of the gastric epithelium. Curr. Med. Chem. 2012, 19:5975-5983.
26. Barker N., Huch M., Kujala P., van de Wetering M., Snippert H.J., Van Es J.H., et al. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010, 6:25-36.
27. Leedham S.J., Brittan M., Preston S.L., McDonald S.A., Wright N.A. The stomach periglandular fibroblast sheath: all present and correct. Gut. 2006, 55:295-296.
28. Karam S.M. Cellular origin ofgastriccancer. Ann. NY Acad. Sci. 2008, 1138:162-168.
29. Lee E.R., Leblond C.P. Dynamic histology of the antral epithelium in the mouse stomach: II. Ultrastructure and renewal of isthmal cells. Am. J. Anat. 1985, 172:205-224.
30. Lee E.R., Leblond C.P. Dynamic histology of the antral epithelium in the mouse stomach: IV. Ultrastructure and renewal of gland cells. Am. J. Anat. 1985, 172:241-259.
31. Qiao X.T., Gumucio D.L. Current molecular markers forgastricprogenitor cells andgastriccancer stem cells. J. Gastroenterol. 2011, 46:855-865.
32. Mills J.C., Shivdasani R.A. Gastricepithelial stem cells. Gastroenterology 2011, 140:412-424.
33. Bjerknes M., Cheng H. Multipotential stem cells in adult mouse gastric epithelium. Am. J. Physiol: Gastrointest Liver Physiol. 2002, 283:G767-G777.
34. Karam S.M., Straiton T., Hassan W.M., Leblond C.P. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells 2003, 21:322-336.
35. van den Brink G.R., Hardwick J.C., Tytgat G.N., Brink M.A., et al. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001, 121:317-328.
36. Karam S.M., Leblond C.P. Dynamics of epithelial cells in the corpus of the mousestomach. I. Identification of proliferative cell types and pinpointing of the stem cell. Anat. Rec. 1993, 236:259-279.
37. Karam S.M., Leblond C.P. Dynamics of epithelial cells in the corpus of the mousestomach. II. Outward migration of pit cells. Anat. Rec. 1993, 236:280-296.
38. Karam S.M., Leblond C.P. Dynamics of epithelial cells in the corpus of the mousestomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat. Rec. 1993, 236:297-313.
39. Karam S.M., Leblond C.P. Dynamics of epithelial cells in the corpus of the mousestomach. V. Behavior of entero-endocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat. Rec. 1993, 236:333-340.
40. McDonald S.A., Greaves L.C., Gutierrez-Gonzalez L., Rodriguez-Justo M., et al. Mechanisms of field cancerization in the humanstomach: the expansion and spread of mutatedgastricstem cells. Gastroenterology 2008, 134:500-510.
41. Li Q., Karam S.M., Gordon J.I. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J. Biol. Chem. 1996, 271:3671-3676.
42. Mills J.C., Andersson N., Hong C.V., Stappenbeck T.S., Gordon J.I. Molecular characterization of mousegastricepithelial progenitor cells. Proc. Natl. Acad. Sci. USA 2002, 99:14819-14824.
43. Akasaka Y., Saikawa Y., Fujita K., Kubota T., et al. Expression of a candidate marker for progenitor cells, Musashi-1, in the proliferative regions of human antrum and its decreased expression in intestinal metaplasia. Histopathology 2005, 47:348-356.
44. Giannakis M., Stappenbeck T.S., Mills J.C., Leip D.G., et al. Molecular properties of adult mousegastricand intestinal epithelial progenitors in their niches. J. Biol. Chem. 2006, 281:11292-11300.
45. Qiao X.T., Ziel J.W., McKimpson W., Madison B.B., Todisco A., et al. Prospective identification of a multilineage progenitor in murinestomachepithelium. Gastroenterology 2007, 133:1989-1998.
46. Barker N., Bartfeld S., Clevers H. Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 2010, 7:656-670.
47. Quante M., Marrache F., Goldenring J.R., Wang T.C. TFF2 mRNA transcript expression marks a gland progenitor cell of thegastricoxyntic mucosa. Gastroenterology 2010, 139:2018-2027.
48. Means A.L., Xu Y., Zhao A., Ray K.C., Gu G. A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis 2008, 46:318-323.
49. Nam K.T., Lee H.J., Sousa J.F., Weis V.G., O'Neal R.L., et al. Mature chief cells are cryptic progenitors for metaplasia in thestomach. Gastroenterology 2010, 139:2028-2037.
50. Ramsey V.G., Doherty J.M., Chen C.C., Stappenbeck T.S., Konieczny S.F., Mills J.C. The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. Development 2007, 134:211-222.
51. Arnold K., Sarkar A., Yram M.A., Polo J.M., et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 2011, 9:317-329.
52. Kouznetsova I., Kalinski T., Meyer F., Hoffmann W. Self-renewal of the human gastric epithelium: new insights from expression profiling using laser microdissection. Mol. BioSyst. 2011, 7:1105-1112.
53. van den Brink G.R. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol. Rev. 2007, 87:1343-1375.
54. Shinohara M., Mao M., Keeley T.M., El-Zaatari M., Lee H.J., et al. Bone morphogenetic protein signaling regulatesgastricepithelial cell development and proliferation in mice. Gastroenterology 2010, 139:2050-2060.
55. Kim T.H., Shivdasani R.A. Notch signaling in stomach epithelial stem cell homeostasis. J. Exp. Med. 2011, 208:677-688.
56. Voon D.C., Wang H., Koo J.K., Nguyen T.A., Hor Y.T., et al. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells 2012, 30:2088-2099.
57. Daley G.Q. The promise and perils of stem cell therapeutics. Cell Stem Cell 2012, 10:740-749.
58. Singh S.R. Stem cell niche in tissue homeostasis, aging and cancer. Curr. Med. Chem. 2012, 19:5965-5974.
59. Bomken S., Fiser K., Heidenreich O., Vormoor J. Understanding the cancer stem cell. Br. J. Cancer 2010, 103:439-445.
60. Nguyen L.V., Vanner R., Dirks P., Eaves C.J. Cancerstemcells: an evolving concept. Nat. Rev. Cancer 2012, 12:133-143.
61. Brunner T.B., Kunz-Schughart L.A., Grosse-Gehling P., Baumann M. Cancerstemcellsas a predictive factor in radiotherapy. Semin. Radiat. Oncol. 2012, 22:151-174.
62. Magee J.A., Piskounova E., Morrison S.J. Cancerstemcells: impact, heterogeneity, and uncertainty. Cancer Cell 2012, 21:283-296.
63. Borovski T., De Sousa E., Melo F., Vermeulen L., Medema J.P. Cancer stem cell niche: the place to be. Cancer Res. 2011, 71:634-639.
64. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
65. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
66. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breastcancercells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
67. Ritchie K.E., Nör J.E. Perivascularstem cellniche inhead and neck cancer. Cancer Lett. 2013, [Epub ahead of print].
68. Bussolati B., Dekel B., Azzarone B., Camussi G. Human renal cancerstem cells. Cancer Lett. 2013, [Epub ahead of print].
69. Lin S.P., Lee Y.T., Yang S.H., Miller S.A., Chiou S.H., Hung M.C., Hung S.C. Colon cancerstem cellsresist antiangiogenesis therapy-induced apoptosis. Cancer Lett. 2013, 328:226-234.
70. Li Y., Kong D., Ahmad A., Bao B., Sarkar F.H. Pancreatic cancerstem cells: Emerging target for designing novel therapy. Cancer Lett. 2013, [Epub ahead of print].
71. Lee T.K., Castilho A., Cheung V.C., Tang K.H., Ma S., Ng I.O. CD24(+)livertumor-initiatingcellsdrive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. CellStem Cell 2011, 9:50-63.
72. Civenni G., Walter A., Kobert N., Mihic-Probst D., Zipser M., et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 2011, 71:3098-3109.
73. Lundi A., Driscoll B. Lung cancerstem cells: Progress and prospects. CancerLett. 2013, [Epub ahead of print].
74. Driessens G., Beck B., Caauwe A., Simons B.D., Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530.
75. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restrictedcellpopulation propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
76. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., Clevers H. Lineage tracing reveals Lgr5+stemcellactivity in mouse intestinal adenomas. Science 2012, 337:730-735.
77. Xu G., Shen J., Ou Yan X., Sasahara M., Su X. Cancerstem cells: the 'heartbeat' of gastric cancer. J. Gastroenterol. 2012, [Epub ahead of print].
78. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., et al. Gastric cancer originating from bone marrow-derivedcells. Science 2004, 306:1568-1571.
79. Takaishi S., Okumura T., Wang T.C. Gastric cancerstem cells. J. Clin. Oncol. 2008, 26:2876-2882.
80. Quante M., Tu S.P., Tomita H., Gonda T., Wang S.S., Takashi S., et al. Bone marrow-derived myofibroblasts contribute to the mesenchymalstem cellniche and promote tumor growth. CancerCell 2011, 19:257-272.
81. Shibata W., Ariyama H., Westphalen C.B., Worthley D.L., et al. Stromalcell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors. Gut. 2013, 62:192-200.
82. Varon C., Dubus P., Mazurier F., Asencio C., Chambonnier L., et al. Helicobacter pylori infection recruits bone marrow-derivedcellsthat participate in gastric preneoplasia in mice. Gastroenterology 2012, 142:281-291.
83. Simon E., Petke D., Böger C., Behrens H.M., Warneke V., Ebert M., Röcken C. The spatial distribution of LGR5+ cells correlates with gastric cancer progression. PLoS One 2012, 7:e35486.
84. Li Q., Jia Z., Wang L., Kong X., Li Q., et al. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice. Gastroenterology 2012, 142:531-542.
85. Quante M., Bhagat G., Abrams J.A., Marache F., Good P., et al. Bile acid and inflammation activategastriccardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012, 21:36-51.
86. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., et al. Identification ofgastriccancer stem cells using the cell surface marker CD44. Stem cells 2009, 27:1006-1020.
87. Zhang C., Li C., He F., Cai Y., Yang H. Identification of CD44+CD24+ gastric cancer stem cells. J. Cancer Res. Clin. Oncol. 2011, 137:1679-1686.
88. Yang L., Ping Y.F., Yu X., Qian F., Guo Z.J., Qian C., Cui Y.H., Bian X.W. Gastric cancerstem-likecellspossess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. CancerLett. 2011, 310:46-52.
89. Chen T., Yang K., Yu J., Meng W., Yuan D., et al. Identification and expansion ofcancerstemcellsin tumor tissues and peripheral blood derived fromgastricadenocarcinoma patients. CellRes. 2012, 22:248-258.
90. Han M.E., Jeon T.Y., Hwang S.H., Lee Y.S., Kim H.J., et al. Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research. Cell Mol. Life Sci. 2011, 68:3589-3605.
91. Jiang J., Zhang Y., Chuai S., Wang Z., Zheng D., Xu F., Zhang Y., Li C., Liang Y., Chen Z. Trastuzumab (herceptin) targets gastric cancer stem cells characterized byCD90phenotype. Oncogene 2012, 31:671-682.
92. Jiang Y., He Y., Li H., Li H.N., Zhang L., Hu W., Sun Y.M., Chen F.L., Jin X.M. Expressions of putativecancerstem cell markers ABCB1, ABCG2, andCD133are correlated with the degree of differentiation ofgastric cancer. Gastric Cancer 2012, 15:440-450.
93. Katsuno Y., Ehata S., Yashiro M., Yanagihara K., Hirakawa K., Miyazono K. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-typegastriccarcinoma-initiating cells is inhibited by TGF-β. J. Pathol. 2012, 228:391-404.
94. Ohkuma M., Haraguchi N., Ishii H., Mimori K., Tanaka F., et al. Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. Ann. Surg. Oncol. 2012, 19:1357-1364.
95. Liu J., Ma L., Xu J., Liu C., Zhang J., Liu J., Chen R., Zhou Y. Spheroid body-forming cells in the humangastric cancercell lineMKN-45 possesscancerstem cellproperties. Int. J. Oncol. 2013, 42:453-459.
96. Fujii Y., Yoshihashi K., Suzuki H., Tsutsumi S., Mutoh H., Maeda S., et al. CDX1 confers intestinal phenotype ongastricepithelialcellsvia induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc. Natl. Acad. Sci. USA 2012, 109:20584-20589.
97. Zhang Y., Huang X. Investigation of doublecortin and calcium/calmodulin-dependent protein kinase-like-1-expressing cells in the mouse stomach. J. Gastroenterol. Hepatol. 2010, 25:576-582.
98. Kikuchi M., Nagata H., Watanabe N., Watanabe H., Tatemichi M., Hibi T. Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia. BMC Gastroenterol. 2010, 10:65.
99. Okumura T., Ericksen R.E., Takaishi S., Wang S.S., Dubeykovskiy Z., Shibata W., Betz K.S., Muthupalani S., Rogers A.B., Fox J.G., Rustgi A.K., Wang T.C. K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res. 2010, 70:8435-8445.
100. Matsuoka J., Yashiro M., Sakurai K., Kubo N., Tanaka H., Muguruma K., Sawada T., Ohira M., Hirakawa K. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J. Surg. Res. 2012, 174:130-135.
101. Sashikawa Kimura M., Mutoh H., Sugano K. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. J Gastroenterol. 2011, 46:1292-1299.
102. Fukui T., Kishimoto M., Nakajima A., Yamashina M., Nakayama S., Kusuda T., Sakaguchi Y., Yoshida K., Uchida K., Nishio A., Matsuzaki K., Okazaki K. The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis. J. Gastroenterol. 2011, 46:456-468.
103. Gupta A., Wodziak D., Tun M., Bouley D.M., Lowe A.W. Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach. J. Biol. Chem. 2013, 288:4321-4333.
104. Reinisch C., Kandutsch S., Uthman A., Pammer J. BMI-1: a protein expressed in stem cells, specialized cells and tumors of the gastrointestinal tract. Histol. Histopathol. 2006, 21:1143-1149.
105. Al-Marzoqee F.Y., Khoder G., Al-Awadhi H., John R., Beg A., Vincze A., Branicki F. Karam SM Upregulation and inhibition of the nuclear translocation of Oct4 during multistep gastric carcinogenesis. Int. J. Oncol. 2012, 41:1733-1743.
106. Zhao P., Li Y., Lu Y. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer 2010, 10:218.
107. Fukamachi H., Shimada S., Ito K., Ito Y., Yuasa Y. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation. Cancer Sci. 2011, 102:1313-1321.
108. Wakamatsu Y., Sakamoto N., Oo H.Z., Naito Y., Uraoka N., Anami K., Sentani K., Oue N., Yasui W. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol. Int. 2012, 62:112-119.
109. Nishikawa S., Konno M., Hamabe A., Hasegawa S., Kano Y., Ohta K., Fukusumi T., Sakai D., Kudo T., Haraguchi N., Satoh T., Takiguchi S., Mori M., Doki Y., Ishii H. Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy. Int. J. Oncol. 2013, 42:1437-1442.
110. Wang T., Ong C.W., Shi J., Srivastava S., Yan B., Cheng C.L., Yong W.P., Chan S.L., Yeoh K.G., Iacopetta B., Salto-Tellez M. Sequential expression of putative stem cell markers in gastric carcinogenesis. Br. J. Cancer 2011, 105:658-665.
111. Lennerz J.K., Kim S.H., Oates E.L., Huh W.J., Doherty J.M., Tian X., Bredemeyer A.J., Goldenring J.R., Lauwers G.Y., Shin Y.K., Mills J.C. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am. J. Pathol. 2010, 177:1514-1533.
112. Peterson A.J., Menheniott T.R., O'Connor L., Walduck A.K., Fox J.G., Kawakami K., Minamoto T., Ong E.K., Wang T.C., Judd L.M., Giraud A.S. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology 2010, 139:2005-2017.
113. Haraguchi N., Utsunomiya T., Inoue H., Tanaka F., Mimori K., Barnard G.F., Mori M. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006, 24:506-513.
114. Fukuda K., Saikawa Y., Ohashi M., Kumagai K., Kitajima M., Okano H., Matsuzaki Y., Kitagawa Y. Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol. 2009, 34:1201-1207.
115. Nishii T., Yashiro M., Shinto O., Sawada T., Ohira M., Hirakawa K. Cancer stem cell-likeSPcells have a high adhesion ability to the peritoneum ingastriccarcinoma. Cancer Sci. 2009, 100:1397-1402.
116. Schmuck R., Warneke V., Behrens H.M., Simon E., Weichert W., Röcken C. Genotypic and phenotypic characterization of side population ofgastriccancer cell lines. Am. J. Pathol. 2011, 178:1792-1804.
117. Ehata S., Johansson E., Katayama R., Koike S., Watanabe A., et al. Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 2011, 30:1693-1705.
118. She J.J., Zhang P.G., Wang X., Che X.M., Wang Z.M. Side population cells isolated from KATO III humangastriccancer cell line have cancer stem cell-like characteristics. World J. Gastroenterol. 2012, 18:4610-4617.
119. Zhang H., Xi H., Cai A., Xia Q., Wang X.X., Lu C., et al. Not all side populationcellscontain cancer stem-likecellsin humangastriccancercelllines. Dig. Dis. Sci. 2013, 58(1):132-139.
120. Cai C., Zhu X. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in humangastriccancer. Mol. Med. Report 2012, 5:1191-1196.
121. Ishimoto T., Oshima H., Oshima M., Kai K., Torii R., Masuko T., Baba H., Saya H., Nagano O. CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 ingastrictumorigenesis. Cancer Sci. 2010, 101:673-678.
122. Song Z., Yue W., Wei B., Wang N., Li T., Guan L., Shi S., Zeng Q., Pei X., Chen L. Sonic hedgehogpathwayis essential for maintenance of cancer stem-like cells in humangastric cancer. PLoS One 2011, 6:e17687.
123. Ding S.Z., Zheng P.Y. Helicobacter pylori infection inducedgastric cancer; advance ingastricstemcell research and the remaining challenges. Gut. Pathog. 2012, 4:18.
124. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007, 133:659-672.
125. Uehara T., Ma D., Yao Y., Lynch J.P., Morales K., Ziober A., Feldman M., Ota H., Sepulveda A.R. H. pylori Infection Is Associated with DNA Damage of Lgr5-Positive Epithelial Stem Cells in the Stomachof Patients withGastricCancer. Dig. Dis. Sci. 2013, 58:140-149.
126. Kuipers E.J., Perez-Perez G.I., Meuwissen S.G. Blaser MJ Helicobacter pylori and atrophic gastritis: importance of the cagA status. J. Natl. Cancer Inst. 1995, 87:1777-1780.
127. Oh J.D., Karam S.M., Gordon J.I. Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc. Natl. Acad. Sci. USA 2005, 102:5186-5191.
128. Giannakis M., Chen S.L., Karam S.M., Engstrand L., Gordon J.I. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc. Natl. Acad. Sci. USA 2008, 105:4358-4363.
129. Ferrand J., Lehours P., Schmid-Alliana A., Mégraud F., Varon C. Helicobacter pylori infection of gastrointestinal epithelialcellsin vitro induces mesenchymalstem cellmigration through an NF-κB-dependent pathway. PLoS One 2011, 6:e29007.
130. Pilpilidis I., Kountouras J., Zavos C., Katsinelos P. Upper gastrointestinal carcinogenesis: H. pylori and stem cell cross-talk. J. Surg. Res. 2011, 166:255-264.
131. Noto J.M., Khizanishvili T., Chaturvedi R., Piazuelo M.B., Romero-Gallo J., et al. Helicobacter pylori promotes the expression of krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo. PLoS One 2013, 8:e54344.
132. Reya T., Morrison S.J., Clarke M.F. Weissman IL Stem cells,cancer, andcancerstem cells. Nature 2001, 414:105-111.
133. Li L., Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006, 66:4553-4557.
134. Cabarcas S.M., Mathews L.A., Farrar W.L. The cancer stem cell niche - there goes the neighborhood?. Int. J. Cancer. 2011, 129:2315-2327.
135. Voog J., Jones D.L. Stemcells and the niche: a dynamic duo. CellStemCell 2010, 6:103-115.
136. Zeng W., Wan R., Zheng Y., Singh S.R., Wei Y. Hypoxia, stem cells and bone tumor. Cancer Lett. 2011, 313:129-136.
137. Sampieri K., Fodde R. Cancer stem cells and metastasis. Semin. Cancer Biol. 2012, 22:187-193.
138. Guo X., Oshima H., Kitmura T., Taketo M.M., Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem. 2008, 283:19864-19871.
139. Kolev Y., Uetake H., Iida S., Ishikawa T., Kawano T., Sugihara K. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann. Surg. Oncol. 2007, 14:2738-2747.
140. Suzuki S., Dobashi Y., Hatakeyama Y., Tajiri R., Fujimura T., Heldin C.H., Ooi A. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density ingastriccancer. BMC Cancer 2010, 10:659.
141. Li M., Gu Y., Zhang Z., Zhang S., Zhang D., Saleem A.F., Zhao X., Sun B. Vasculogenicmimicry: a new prognostic sign of gastric adenocarcinoma. Pathol. Oncol. Res. 2010, 16:259-266.
142. Jiang J., Liu W., Guo X., Zhang R., Zhi Q., Ji J., et al. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene 2011, 30:4498-4508.
143. Liu L., Ning X., Sun L., Zhang H., Shi Y., Guo C., Han S., Liu J., Sun S., Han Z., Wu K., Fan D. Hypoxia-inducible factor-1 alpha contributes tohypoxia-induced chemoresistance ingastriccancer. Cancer Sci. 2008, 99:121-128.
144. Komuro A., Yashiro M., Iwata C., Morishita Y., Johansson E., et al. Diffuse-typegastriccarcinoma: progression, angiogenesis, and transforming growth factor beta signaling. J. Natl.CancerInst. 2009, 101:592-604.
145. Johansson E., Komuro A., Iwata C., Hagiwara A., Fuse Y., et al. Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted diffuse-typegastriccarcinoma. CancerSci. 2010, 101:2398-2403.
146. Van Cutsem E., de Haas S., Kang Y.K., Ohtsu A., et al. Bevacizumab in combination with chemotherapy as first-line therapy in advancedgastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial. J. Clin. Oncol. 2012, 30:2119-2127.
147. Yakisich J.S. Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment. Drugs Ther. Stud. 2012, 2:e10.
148. Liu X., Sun Y., Guo J., Ma H., Li J., Dong B., Jin G., Zhang J., Wu J., Meng L., Shou C. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int. J. Cancer 2006, 118(8):1922-1929.
149. Zhi Q.M., Chen X.H., Ji J., Zhang J.N., Li J.F., Cai Q., Liu B.Y., Gu Q.L., Zhu Z.G., Yu Y.Y. Salinomycin can effectively kill ALDH(high) stem-like cells ongastriccancer. Biomed. Pharmacother. 2011, 65:509-515.
150. Akagi H., Higuchi H., Sumimoto H., Igarashi T., Kabashima A., Mizuguchi H., et al. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis ingastric cancercells. Gastric cancer 2013, 16:100-110.
151. Ruan J., Ji J., Song H., Qian Q., Wang K., Wang C., Cui D. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivogastric cancer. Nanoscale Res. Lett. 2012, 7:309.
152. Ruan J., Song H., Li C., Bao C., Fu H., Wang K., Ni J., Cui D. DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivoGastric CancerCells. Theranostics 2012, 2:618-628.
153. Ruan J., Song H., Qian Q., Li C., Wang K., Bao C., Cui D. HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy ofgastric cancer. Biomaterials 2012, 33:7093-7102.
154. Park J., Ku M., Kim E., Park Y., Hong Y., Haam S., Cheong J.H., et al. CD44-specific supramolecular hydrogels for fluorescence molecular imaging of stem-likegastric cancercells. Integr. Biol. 2013, 5:669-672.
155. Zieker D., Bühler S., Ustündag Z., Königsrainer I., et al. Induction of tumor stem cell differentiation-novel strategy to overcome therapy resistance ingastric cancer. Langenbecks Arch Surg. 2013, 398:603-608.
156. Wang B., Liu J., Ma L.N., Xiao H.L., Wang Y.Z., et al. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+)gastric cancercells via attenuating Wnt signaling. J. Gastroenterol. 2012, [Epub ahead of print].
157. Zhan Y.Y., He J.P., Chen H.Z., Wang W.J., Cai J.C. Orphan receptor TR3 is essential for the maintenance of stem-like properties ingastric cancer cells. CancerLett. 2013, 329:37-44.
158. Tian T., Zhang Y., Wang S., Zhou J., Xu S. Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer. J. Biomed. Res. 2012, 26:336-345.
159. Kim K.Y., Yi B.R., Lee H.R., Kang N.H., Jeung E.B., Kim S.U., Choi K.C. Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use. Int. J. Oncol. 2012, 40:1097-1104.
160. Zhu X., Su D., Xuan S., Ma G., Dai Z., Liu T., Tang D., Mao W., Dong C. Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood- derived mesenchymal stem cells. Gastric cancer 2013, 16:155-166.